NCT03402893View on ClinicalTrials.gov

The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

February 28, 2018

Conditions
Acne VulgarisPost Inflammatory Hyperpigmentation
Interventions
DRUG

ONEXTON Topical Gel

Onexton gel applied once daily to face

Trial Locations (1)

40217

DermResearch, PLLC, Louisville

Sponsors
All Listed Sponsors
lead

Derm Research, PLLC

OTHER